CMB305
V943A-001
Phase 2 mab terminated
Quick answer
CMB305 for Sarcoma is a Phase 2 program (mab) at Design Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Sarcoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated